The tweet was deleted by the author.
But we saved everything 🙂.
NeoGenomics is inviting attendees to visit its booth at the USCAP 115th Annual Meeting, focusing on the latest innovations in precision oncology.
The company aims to highlight new developments in pathology and diagnostics, reinforcing its commitment to driving advances in cancer diagnostics. The event is expected to attract leading experts in the field, providing a platform for NeoGenomics to engage with the medical community and demonstrate its solutions for oncology diagnostics.
NeoGenomics has previously previewed its planned activities at booth 639 for USCAP2026, inviting attendees to book meetings at the pathology forum. The company is also scheduled to present research on spatial biology strategies to address immunotherapy resistance at a leading U.S. event, according to past announcements. These engagements form part of NeoGenomics’ ongoing participation in major industry conferences.